| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/20/2026 | ±3.5% | +11.3% | under-priced |
| 07/21/2026 | ±4.2% | -3.9% | over-priced |
| 04/21/2026 | ±2.8% | -3.0% | under-priced |
| 02/19/2026 | ±4.2% | +1.4% | over-priced |
| 10/21/2025 | ±2.7% | -0.5% | over-priced |
| 07/22/2025 | ±2.0% | -8.2% | under-priced |
| 04/22/2025 | ±3.2% | +13.8% | under-priced |
| 02/20/2025 | ±2.5% | -0.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.79 | $1.7B | $212M |
| Q2 FY2026 | $1.54 | $1.7B | $184M |
| Q1 FY2026 | $1.42 | $1.6B | $172M |
| Q4 FY2025 | — | $1.6B | $176M |
Equifax, Incorporated (EFX) reports in 83 days, with the next report estimated for 01/19/2027. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 5.4% on average — the market has been roughly fair on EFX's earnings risk. Fundamentals into the print: EPS up 38.8% year-over-year, revenue up 9.6%. QuantLogix's live 5-factor engine currently reads EFX as a neutral at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →